N° 015 · The Directory

Selank

Russian heptapeptide for anxiety reduction. Tuftsin analog approved as a pharmaceutical in Russia.

B-Tier Cognitive Research peptide (US) / Rx (Russia)

New to peptides? Start with the foundations ->

What it does - plain English

Selank is a synthetic seven-amino-acid peptide (a small chain of protein building blocks) developed at the Russian Institute of Molecular Genetics in the 1990s. It's a synthetic analog of tuftsin - a small peptide your spleen makes naturally that helps regulate both immune activity and central nervous system function.

The Russian research claims it reduces anxiety, supports memory, and provides nootropic (cognitive-enhancement) effects without the sedation, dependence, or withdrawal risks that come with benzodiazepines - the drug class that includes Valium and Xanax.

It is not a stimulant. It is not a sedative. The proposed effect is anxiolytic: it reduces anxiety without knocking you out or creating a rebound when you stop. That's the claim. The evidence base, while real, is almost entirely Russian.

Selank is approved as a prescription medication in Russia for generalized anxiety disorder. It is not approved in the US or most Western countries.

Status

B-tier within the cognitive-peptide category. The Russian trials - most notably the Zozulya et al. work - showed measurable anti-anxiety effects in clinical populations. The proposed mechanism, modulation of GABA, dopamine, and serotonin pathways, is biologically plausible. Western replication is sparse, which is the honest reason it sits at B and not higher.

The peptide research community treats Selank and Semax (a related Russian peptide for cognitive support) as the two most credible entries from the Russian research lineage. If you're building a reading list on cognitive peptides with actual clinical trials behind them, those two are the starting point.

Legal status

Selank is approved as a prescription medication in Russia for generalized anxiety disorder. Outside Russia it is not approved anywhere by a Western regulatory body. It is also not on the FDA's banned list in the US.

What this means in practice: you cannot walk into a US pharmacy and buy it. The two realistic paths:

International pharmacy import - Russian-manufactured Selank nasal spray is what the clinical trials used. Personal-use import is a legal gray zone: permitted in some states, restricted in others. Customs seizure is possible.
Research peptide vendors - sold legally in the US as "for research use only, not for human consumption." Purity varies. No consumer protection. Always require a COA (Certificate of Analysis - the lab report confirming purity and concentration) before buying.

Often administered intranasally - as a nasal spray - rather than injected. The nasal route is how the Russian pharmaceutical formulation works and how the trials were conducted.

Where to source

Two paths. First: international pharmacy import of authentic Russian-pharmaceutical Selank in nasal-spray form. This matches the trial formulation. Legal-gray-zone for personal use depending on your state.

Second: US research peptide vendors. Always ask for a COA per batch. No COA, no buy. Verify formulation (the nasal-spray stabilizer concentration matters) and verify that the listed concentration matches what you expect.

Research-grade Selank from US peptide vendors may not match the Russian pharmaceutical formulation used in the trials. The difference in formulation and concentration can affect how the peptide behaves. Check both.

Subscribe below to get vendor reviews and sourcing updates in the weekly dispatch.

Two studies worth reading

Generalized anxiety disorder trial

Zozulya, A. et al., Bulletin of Experimental Biology and Medicine

Russian RCT in patients with generalized anxiety disorder. Selank produced anti-anxiety effects comparable to medazepam (a benzodiazepine), but without sedation, drowsiness, or withdrawal. This is the trial that anchors the anxiolytic claim. The core paper.

Mechanism review covering GABA-related effects

Volchegorskii, I. et al., Eksperimentalnaia i Klinicheskaia Farmakologiia

Comparative review covering Selank's neurotransmitter modulation and how it stacks against established Russian and Western nootropics including piracetam and amitriptyline. Important for understanding where the peptide sits in the cognitive-protocol literature.

From the Editor

My take: Selank is the Russian cognitive peptide where the clinical evidence is more substantial than for Epitalon or Pinealon. The anxiolytic data, though all from one research lineage, is methodologically reasonable. If you're researching cognitive peptides with actual clinical trials behind them, Selank and Semax are where to start.

What I'd tell my dad: anxiety has FDA-approved options that are well-studied. SSRIs, buspirone, and CBT are first-line. Selank is a curiosity, not a substitute for treatment. If you're researching it, it's because the FDA-approved options have failed or had unacceptable side effects. That's a real scenario. But start with the standard-of-care options first.

What I'd skip: Selank stacks combining it with Semax, Pinealon, and Epitalon as a Russian-peptide cognitive bundle. Single-peptide, single-vendor, COA per batch. The combination products are where vendor quality breaks down most. The failure mode isn't the combination in theory - it's that multi-peptide blends make it impossible to verify what you actually got.

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026·05·04 · Status reviewed weekly